Patents by Inventor Jamal` Lewis

Jamal` Lewis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antigen-specific, tolerance-inducing microparticles and uses thereof
    Patent number: 10987314
    Abstract: The present invention provides antigen-specific, tolerance-inducing microparticles for the targeted delivery of therapeutic agents to immune cells. In addition, the present invention allows for sustained release of therapeutic agents for a prolonged period of time. Also provided are therapeutic uses of the present invention for the prevention and/or treatment of immune diseases and autoimmune disorders. In a specific embodiment, the present invention provides treatment for type 1 diabetes.
    Type: Grant
    Filed: July 1, 2018
    Date of Patent: April 27, 2021
    Assignee: University of Florida Research Foundation, Inc.
    Inventors: Benjamin George Keselowsky, Jamal Lewis, Abhinav Acharya, Michael J. Clare-Salzler
  • Polymeric particles, method for cytosolic delivery of cargo, methods of making the particles
    Patent number: 10512607
    Abstract: Embodiments of the present disclosure include particles, methods of making particles, methods of delivering an active agent using the particle, and the like.
    Type: Grant
    Filed: October 25, 2016
    Date of Patent: December 24, 2019
    Assignees: Vanderbilt University, University of Florida Research Foundation, Inc.
    Inventors: Benjamin G. Keselowsky, Jamal Lewis, Lawrence Premasiri Fernando, Craig L. Duvall, Brian C. Evans, Lirong Yang
  • ANTIGEN-SPECIFIC, TOLERANCE-INDUCING MICROPARTICLES AND USES THEREOF
    Publication number: 20180303760
    Abstract: The present invention provides antigen-specific, tolerance-inducing microparticles for the targeted delivery of therapeutic agents to immune cells. In addition, the present invention allows for sustained release of therapeutic agents for a prolonged period of time. Also provided are therapeutic uses of the present invention for the prevention and/or treatment of immune diseases and autoimmune disorders. In a specific embodiment, the present invention provides treatment for type 1 diabetes.
    Type: Application
    Filed: July 1, 2018
    Publication date: October 25, 2018
    Inventors: BENJAMIN GEORGE KESELOWSKY, JAMAL LEWIS, ABHINAV ACHARYA, MICHAEL J. CLARE-SALZLER
  • Antigen-specific, tolerance-inducing microparticles and uses thereof
    Patent number: 10016371
    Abstract: The present invention provides antigen-specific, tolerance-inducing microparticles for the targeted delivery of therapeutic agents to immune cells. In addition, the present invention allows for sustained release of therapeutic agents for a prolonged period of time. Also provided are therapeutic uses of the present invention for the prevention and/or treatment of immune diseases and autoimmune disorders. In a specific embodiment, the present invention provides treatment for type 1 diabetes.
    Type: Grant
    Filed: October 24, 2011
    Date of Patent: July 10, 2018
    Assignee: UNIVERSITY OF FLORIDA RESEARCH FOUNDATION
    Inventors: Benjamin George Keselowsky, Jamal Lewis, Abhinav Acharya, Michael J. Clare-Salzler
  • POLYMERIC PARTICLES, METHOD FOR CYTOSOLIC DELIVERY OF CARGO, METHODS OF MAKING THE PARTICLES
    Publication number: 20170119668
    Abstract: Embodiments of the present disclosure include particles, methods of making particles, methods of delivering an active agent using the particle, and the like.
    Type: Application
    Filed: October 25, 2016
    Publication date: May 4, 2017
    Inventors: Benjamin G. Keselowsky, Jamal Lewis, Lawrence Premasiri Fernando, Craig L. Duvall, Brian C. Evans, Lirong Yang
  • ANTIGEN-SPECIFIC, TOLERANCE-INDUCING MICROPARTICLES AND USES THEREOF
    Publication number: 20130287729
    Abstract: The present invention provides antigen-specific, tolerance-inducing microparticles for the targeted delivery of therapeutic agents to immune cells. In addition, the present invention allows for sustained release of therapeutic agents for a prolonged period of time. Also provided are therapeutic uses of the present invention for the prevention and/or treatment of immune diseases and autoimmune disorders. In a specific embodiment, the present invention provides treatment for type 1 diabetes.
    Type: Application
    Filed: October 24, 2011
    Publication date: October 31, 2013
    Applicant: UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC.
    Inventors: Benjamin George Keselowsky, Jamal` Lewis, Abhinav Acharya, Michael J. Clare-Salzler, Mark A. Atkinson, Clive Henry Wasserfall, Chang Qing Xia, Todd M. Brusko